Brigit Biofarmaka Teknologi Tbk. vs Trikomsel Oke Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Trikomsel Oke Tbk. trades at Rp426 (market cap 11.08T). The key difference: Trikomsel Oke Tbk. is far larger — about 66.7× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| OBAT | TRIO | |
|---|---|---|
Market Cap | 166.01B | 11.08T |
Volume | 324K | — |
Lot | 3.24K | — |
Turnover | 77.68M | — |
Average Price | 239.75 | — |
Value | 77.68M | — |
Indicative Equilibrium Price | 240 | — |
Indicative Equilibrium Volume | 1 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Trikomsel Oke (the company) was established under its original name of PT Trikomsel Citrawahana based on Notarial Deed No. 11 dated August 21, 1996 of Mrs. Liliana Indrawati Tanuwidjaja, S.H.The Companys articles of association has been amended several times, most recently by notarial deed No. 25 of Fathiah Helmi, S.H., dated Oct 29, 2008, concerning among others, the change in the Company’s authorized stock and paid-up capital
Read more on TRIO →